两家公司表示,在合作的初始阶段,Ares开发了一个数字抗感染平台,将微生物学实验室实践与先进的生物信息学和人工智能方法相结合,以帮助识别有效的抗菌化合物...查看全文
蹊之美股生物医药2021-10-08 00:15
作者:林出
微信公众号:蹊之美股生物医药 / CaesarBiotech
Gainers:
Voyager Therapeutics (NASDAQ:VYGR) +56%
Acer Therapeutics (NASDAQ:ACER) +16%
Molecular Partners (NASDAQ:MOLN) +10%
Rafael (NYSE:RFL) +6%
Arcturus Therapeutics (NASDA...查看全文
东哥_Singapore2021-03-08 23:42
$Jaguar Health(JAGX)$ 给力点啊,速度冲2.5!刚才在2.9的OPGN跟1.85的你之间,最后选的你!不要让我失望啊!OPGN已经爆拉了!!!$OpGen(OPGN)$查看全文
$OpGen(OPGN)$ EFFECT - Notice of Effectiveness Filed: 2019-10-23 AccNo: 9999999995-19-002371 Size: 1 KB 网页链接
$OpGen(OPGN)$ FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses Filed: 2019-10-18 AccNo: 0001079973-19-000526 Size: 5 MB 网页链接
$OpGen(OPGN)$ S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933 Filed: 2019-10-17 AccNo: 0001079973-19-000524 Size: 3 MB 网页链接
$OpGen(OPGN)$ S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933 Filed: 2019-10-15 AccNo: 0001079973-19-000512 Size: 4 MB 网页链接
$OpGen(OPGN)$ 8-K - Current report Filed: 2019-09-18 AccNo: 0001553350-19-000966 Size: 14 KBItem 8.01: Other Events 网页链接
$OpGen(OPGN)$ S-1 - General form for registration of securities under the Securities Act of 1933 Filed: 2019-09-16 AccNo: 0001553350-19-000952 Size: 3 MB 网页链接
$OpGen(OPGN)$ 8-K - Current report Filed: 2019-09-04 AccNo: 0001553350-19-000909 Size: 5 MBItem 1.01: Entry into a Material Definitive AgreementItem 7.01: Regulation FD DisclosureItem 9.01: Financial Statements and Exhibits 网页链接
$OpGen(OPGN)$ 美东时间 2019-08-29 拆合股: 20合1 网页链接
$OpGen(OPGN)$ 8-K - Current report Filed: 2019-08-28 AccNo: 0001079973-19-000491 Size: 864 KBItem 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal YearItem 9.01: Financial Statements and Exhibits 网页链接
$OpGen(OPGN)$ 8-K - Current report Filed: 2019-08-23 AccNo: 0001553350-19-000889 Size: 15 KBItem 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing 网页链接